LYUBOV VOYEVIDKO: Open Payments
NPI 1649987512 · UTICA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 39 payments from 16 companies in 2025. Trend: 2023 $1,776 · 2024 $1,597 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $263 |
| Dendreon Pharmaceuticals LLC | 4 | $248 |
| Sumitomo Pharma America, Inc. | 5 | $88 |
| Endo USA, Inc. | 4 | $78 |
| Medtronic, Inc. | 1 | $77 |
| Janssen Biotech, Inc. | 4 | $70 |
| PFIZER INC. | 3 | $60 |
| Ferring Pharmaceuticals Inc. | 1 | $58 |
| Olympus America Inc. | 3 | $57 |
| ABBVIE INC. | 2 | $34 |
Products named: KEYTRUDA, PROVENGE, ORGOVYX, XTANDI, XIAFLEX, INTERSTIM, ERLEADA, ADSTILADRIN.
Industry payments across MI — which companies pay providers there.
